RxDoctor Payments Data

William Blythe, MD

Otolaryngology · Opelika, ALNPI 1851321053

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 73.5% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $10,031 and has fallen 86.1% since, to $1,397 in 2025. Among otolaryngology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,901in general payments, 2019–2025

Across 144 payments — averaging $131.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$14K
  • Cochlear Americas$2K
  • Sanofi$451
  • GSK$375
  • Advanced Bionics, LLC$303
  • Neurent Medical Limited$300
  • plus $1K from 15 others
$112,555in research payments, 2019–2025

Across 27 payments — averaging $4168.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurent Medical Limited$87K
  • Aerin Medical Inc.$26K

What the payments were for

  • Consulting fees$10,12554%
  • Travel & lodging$1,6089%
  • Food & beverage$7,16838%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,901 in reported general payments places this provider in the 90th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama

Medicare billing

Part B allowed, 2024
$163,164
Medicare patients
440
Services billed
2,815

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$48,077
Azelastine Hcl170$5,534
Fluticasone Propionate191$2,931
Levothyroxine Sodium157$2,125
Fluocinolone Acetonide Oil38$2,048
Pantoprazole Sodium129$1,603
Ipratropium Bromide38$1,467
Ofloxacin32$1,284
Montelukast Sodium56$1,257
Levocetirizine Dihydrochloride103$1,220
Mupirocin107$892
Prednisolone20$803
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen74$678
Azithromycin30$322
Cephalexin38$290

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Opelika

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →